Willner & Heller LLC Purchases 229 Shares of Humana Inc. (NYSE:HUM)

Willner & Heller LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 17.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,562 shares of the insurance provider’s stock after buying an additional 229 shares during the period. Willner & Heller LLC’s holdings in Humana were worth $495,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Pzena Investment Management LLC increased its holdings in shares of Humana by 538.7% during the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after acquiring an additional 1,955,375 shares during the last quarter. Ontario Teachers Pension Plan Board raised its position in shares of Humana by 11,647.2% in the first quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after purchasing an additional 1,050,459 shares during the period. Marshall Wace LLP lifted its stake in shares of Humana by 118.9% during the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after buying an additional 774,085 shares during the last quarter. Steadfast Capital Management LP bought a new stake in shares of Humana during the 1st quarter worth about $158,813,000. Finally, Allspring Global Investments Holdings LLC grew its stake in Humana by 255.4% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 620,793 shares of the insurance provider’s stock valued at $215,241,000 after buying an additional 446,124 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HUM. Barclays cut their price objective on shares of Humana from $364.00 to $250.00 and set an “equal weight” rating for the company in a research report on Thursday. Piper Sandler lowered Humana from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. TD Cowen downgraded Humana from a “buy” rating to a “hold” rating and dropped their target price for the stock from $402.00 to $261.00 in a report on Monday, October 7th. Royal Bank of Canada decreased their price target on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Finally, Bank of America cut shares of Humana from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $376.00 to $247.00 in a research note on Wednesday, October 2nd. One analyst has rated the stock with a sell rating, nineteen have given a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $315.33.

Humana Price Performance

NYSE:HUM traded up $6.63 on Friday, hitting $258.07. The company had a trading volume of 4,020,151 shares, compared to its average volume of 1,811,433. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $530.54. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $31.10 billion, a price-to-earnings ratio of 16.07, a PEG ratio of 1.91 and a beta of 0.50. The firm has a 50 day moving average of $324.76 and a two-hundred day moving average of $340.20.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. The company had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. Humana’s revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the company earned $8.94 EPS. On average, research analysts anticipate that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.37%. Humana’s dividend payout ratio is presently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.